Atlas Trials

A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients

Clinical trial NCT03102398 · UNKNOWN

Trial details

NCT number
NCT03102398
Sponsor
Tritech Biopharmaceuticals Co., Ltd.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Erectile Dysfunction
Start date
2017-03-31
Primary completion
2018-01-31
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.